Gene · 4744
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNA-Seq Analysis of Trans-Differentiated ARPE-19 Cells Transduced by AAV9-AIPL1 Vectors. | Int J Mol Sci | 2023 | 38203368 | PubTator, text mining | PubMed |
| Human placenta-derived mesenchymal stem cells stimulate neuronal regeneration by promoting axon growth and restoring neuronal activity. | Front Cell Dev Biol | 2023 | 38188022 | PubTator, text mining | PubMed |
| Neurofilaments in health and Charcot-Marie-Tooth disease. | Front Cell Dev Biol | 2023 | 38164457 | PubTator, text mining | PubMed |
| Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioi. | Front Neurol | 2023 | 38162454 | PubTator, text mining | PubMed |
| Sensory innervation of masseter, temporal and lateral pterygoid muscles in common marmosets. | Sci Rep | 2023 | 38155190 | PubTator, text mining | PubMed |
| Long-Term Dysfunction of Taste Papillae in SARS-CoV-2. | NEJM Evid | 2023 | 38145006 | PubTator, text mining | PubMed |
| TIMAP, a Regulatory Subunit of Protein Phosphatase 1, Inhibits In Vitro Neuronal Differentiation. | Int J Mol Sci | 2023 | 38139189 | PubTator, text mining | PubMed |
| Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis. | Antibodies (Basel) | 2023 | 38131803 | PubTator, text mining | PubMed |
| Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma. | Neurooncol Adv | 2023 | 38130900 | PubTator, text mining | PubMed |
| ATAT: Automated Tissue Alignment and Traversal in Spatial Transcriptomics with Self-Supervised Learning. | bioRxiv | 2023 | 38106010 | PubTator, text mining | PubMed |
| Immunology of amyotrophic lateral sclerosis - role of the innate and adaptive immunity. | Front Neurosci | 2023 | 38105925 | PubTator, text mining | PubMed |
| Shedding light on neurofilament involvement in cognitive decline in obstructive sleep apnea and its possible role as a biomarker. | Front Psychiatry | 2023 | 38098628 | PubTator, text mining | PubMed |
| Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness. | Alzheimers Dement (Amst) | 2023 | 38094990 | PubTator, text mining | PubMed |
| Serum spectrin breakdown product and neurofilament heavy in predicting outcome after cardiac arrest: A diagnostic accuracy study. | Heliyon | 2023 | 38076158 | PubTator, text mining | PubMed |
| Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status. | Front Neurol | 2023 | 38073633 | PubTator, text mining | PubMed |
| Serum amyloid P component accumulates and persists in neurones following traumatic brain injury. | Open Biol | 2023 | 38052249 | PubTator, text mining | PubMed |
| PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study. | Aging (Albany NY) | 2023 | 38048211 | PubTator, text mining | PubMed |
| Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era. | Front Neurol | 2023 | 38020652 | PubTator, text mining | PubMed |
| Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases. | J Alzheimers Dis | 2023 | 38007650 | PubTator, text mining | PubMed |
| Identifying the Phenotypes of Diffuse Axonal Injury Following Traumatic Brain Injury. | Brain Sci | 2023 | 38002566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4744/papers?page=8